BPC-157 vs TB-500: A Research Comparison
BPC-157 and TB-500 are the two peptides most frequently studied together in connective-tissue and cell-migration research. They are often paired precisely because they act through different proposed mechanisms, which is also why they are studied as a blend. This comparison covers how each works in research models, how they differ, and how to verify research-grade material.
Side-by-side
| | BPC-157 | TB-500 |
| --- | --- | --- |
| Origin | Partial sequence of a gastric-juice protein | Fragment of thymosin β4 |
| Class | Synthetic pentadecapeptide (15 aa) | Thymosin β4-related peptide |
| Proposed mechanism | Angiogenesis, nitric-oxide signaling | Actin regulation, cell migration |
| Studied in | Vascular + GI + connective-tissue models | Cytoskeletal + cell-migration models |
| Appearance | White powder | White powder |
Different mechanisms, complementary research
- BPC-157 is studied around angiogenesis (new blood-vessel formation) and nitric-oxide (NO) signaling, reflecting its gastric-protein origin and vascular-model focus.
- TB-500 is studied around actin regulation — it sequesters G-actin and influences cytoskeletal dynamics — and the cell migration that follows in tissue-repair models.
Because one is studied on the vascular/signaling side and the other on the cytoskeletal/migration side, researchers frequently pair them to study complementary pathways in the same model.
The BPC-157 / TB-500 blend
The two are commonly offered and studied as a blend for exactly this reason. In a blended research preparation, the same reconstitution and concentration principles apply — record the mg of each component and the total mL of bacteriostatic water to document the concentration of each.
Both peptides (and the blend) offered here are research chemicals for laboratory use only. Not for use in humans or animals.
Which to choose for a study
- Studying angiogenesis or NO signaling → BPC-157. See what is BPC-157 →.
- Studying actin regulation or cell migration → TB-500. See what is TB-500 →.
- Studying complementary tissue-repair pathways → the blend.
Reconstitution and handling for research
The blend ships as a lyophilized (freeze-dried) powder for laboratory use. Standard research handling:
- Bring to room temperature before opening so condensation does not form on the cold vial.
- Add bacteriostatic water slowly down the inside wall — never spray directly onto the lyophilized cake. Let it dissolve without shaking; a gentle swirl is enough.
- Concentration is simple arithmetic: milligrams of peptide divided by milliliters of water added equals the concentration in mg/mL. For example, 10 mg reconstituted in 2 mL of bacteriostatic water yields a 5 mg/mL research stock solution.
- Keep it sterile. Wipe the stopper with alcohol, use a fresh sterile needle to draw solvent, and work in a clean area.
For a full walk-through, see our peptide reconstitution guide →.
How research-grade material is verified
Every batch from a credible US supplier should arrive with a third-party Certificate of Analysis (COA) for that exact lot. Peptide Technologies publishes a COA on every batch and ties it to a QR code on the vial. A complete COA reports:
- Identity — mass spectrometry (ESI-MS) confirming the observed mass matches the theoretical mass of the target sequence.
- Purity — reverse-phase HPLC, reported as percent peak area at a fixed wavelength (typically 220 nm). Research-grade material is ≥99% by area.
- Net content — gravimetric confirmation the vial holds the stated mass within tolerance.
- Endotoxin — LAL assay below research-grade thresholds.
If a vendor cannot show a lot-specific COA, you cannot verify what is in the vial. Browse the full COA library →
How to source research-grade material
For laboratory research, sourcing quality comes down to a few checks:
- Lot-specific COA from an accredited, independent laboratory — not a generic marketing PDF.
- HPLC purity ≥99% by peak area, with the chromatogram shown.
- US synthesis and finishing, so the chain of custody is documented end to end.
- Cold-chain shipping for lyophilized material, so the product arrives stable.
Peptide Technologies meets each of these and shows the live competitor price on every product page. See how our pricing compares →
FAQ
What is the difference between BPC-157 and TB-500?
They act through different proposed mechanisms in tissue-repair research: BPC-157 through angiogenesis and nitric-oxide signaling, TB-500 through actin regulation and cell migration.
Why are BPC-157 and TB-500 studied together?
Because their mechanisms are complementary — one on the vascular/signaling side, one on the cytoskeletal/migration side — they are frequently paired and offered as a blend.
Is BPC-157 or TB-500 better?
Neither is "better"; they are studied for different pathways. The right choice depends on the research question.
How are they verified?
Research-grade BPC-157 and TB-500 are verified by HPLC for purity, mass spectrometry for identity, and an LAL endotoxin assay, reported on a lot-specific third-party COA.
Are they research chemicals?
Yes. Both, and the blend, are research chemicals for laboratory use only. Not for use in humans or animals.
